2nd Anti-Fibrotic Drug Development Summit (AFDD)

Conference themes
AFDD (Anti-Fibrotic Drug Development) is the industry definitive fibrosis forum for drug developers focused on organ specific indications to gain cross-disciplinary insights into the next generation of candidates.

Join fibrosis leaders as they address challenges in anti-fibrotic drug development through a tighter lens.

Professional congress organizer (PCO)
Hanson Wade

Notes
Speakers: Alexey Lugovsky, Chief Development Officer Morphic, Therapeutics, Andy Blanchard, Director External Discovery, GSK, Charles Theuer, Chief Executive Officer, Tracon Pharmaceuticals

https://go.evvnt.com/263771-1?pid=4832

Ms. Aarti Diwan